Prophylaxis and treatment of invasive candidiasis in the intensive care setting

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
Luis Ostrosky-Zeichner

Abstract

The term "invasive candidiasis" encompasses a group of infections of increasing relevance in the intensive care setting. Prophylaxis is an attractive strategy when dealing with diseases of high prevalence, morbidity, and mortality. The success of prophylaxis is determined by the selection of a population at high risk and the use of the safest and most effective drug. Although risk factors for this disease are known, risk assessment strategies need to be developed to predict a high likelihood of disease so that targeted prophylaxis can be offered. Recent advances in antifungal therapy, such as development of the azoles and echinocandins, have resulted in excellent prophylactic and therapeutic choices for the management of this problem.

References

Oct 1, 1990·Journal of Clinical Microbiology·P PhillipsM Kelly
Jun 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W R Jarvis
Jun 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R P Wenzel
May 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M A PfallerM G Rinaldi
Nov 3, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A M RentzR Bowden
Dec 1, 1998·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·M NucciN Spector
Jul 9, 1999·Critical Care Medicine·J H Rex, J D Sobel
Sep 7, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M S Rangel-FraustoR P Wenzel
Jan 27, 2000·Medical Mycology·B ChristenssonL Larsson
Apr 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J H RexJ E Edwards
Jun 16, 2000·International Journal of Antimicrobial Agents·P MuñozE Bouza
Feb 24, 2001·Medical Mycology·E ReissR M Zancopé-Oliveira
Apr 3, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J H Rex, J D Sobel
Jun 22, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·H M BlumbergUNKNOWN National Epidemiology of Mycoses Survey(NEMIS) Study Group
Jun 22, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J D Sobel, J H Rex
Oct 5, 2001·Clinical Microbiology Reviews·J H RexD W Warnock
Nov 10, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M Nucci, E Anaissie
Dec 4, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S AsciogluUNKNOWN Mycoses Study Group of the National Institute of Allergy and Infectious Diseases
Jan 26, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marcio Nucci, Elias Anaissie
May 15, 2002·The Journal of Pediatrics·Lisa A GrohskopfUNKNOWN Pediatric Prevention Network
Jun 1, 2002·The Journal of Antimicrobial Chemotherapy·David W Denning
Jul 20, 2002·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Z Erjavec, P E Verweij
Sep 26, 2002·Journal of Critical Care·Ghislaine LeleuUNKNOWN Collège des Utilisateurs de Base de Données en Réanimation
Oct 2, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John H Rex, Michael A Pfaller
Dec 10, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·François StéphanStéphane Bretagne
Dec 19, 2002·Transplant Infectious Disease : an Official Journal of the Transplantation Society·B D Alexander
Dec 20, 2002·The New England Journal of Medicine·Jorge Mora-DuarteUNKNOWN Caspofungin Invasive Candidiasis Study Group
Mar 11, 2003·Critical Care Medicine·Hervé DupontJean-Marie Desmonts
Apr 30, 2003·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·William J Steinbach, John R Perfect
May 15, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John H RexUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group
Jun 26, 2003·Trends in Microbiology·Frank C OddsNeil A R Gow
Aug 28, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasUNKNOWN NIAID Mycoses Study Group
Oct 15, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Olafur GudlaugssonDaniel Diekema
Nov 25, 2003·Seminars in Perinatology·Daniel K BenjaminWilliam J Steinbach

❮ Previous
Next ❯

Citations

Jul 23, 2009·The Journal of Antimicrobial Chemotherapy·Matteo BassettiClaudio Viscoli
Mar 22, 2006·Critical Care Medicine·John H Rex
Aug 19, 2006·Critical Care Medicine·Pamela A Lipsett
Jun 30, 2005·Current Opinion in Infectious Diseases·Jacques BilleThierry Calandra
Jan 16, 2007·Clinical Microbiology Reviews·M A Pfaller, D J Diekema
Apr 12, 2012·Critical Care : the Official Journal of the Critical Care Forum·Mariateresa GiglioFilomena Puntillo
Dec 15, 2010·Critical Care : the Official Journal of the Critical Care Forum·Matteo BassettiClaudio Viscoli
Sep 10, 2008·Drugs·Maria J G T RüpingOliver A Cornely
Jan 22, 2010·Critical Reviews in Microbiology·Michael A Pfaller, Daniel J Diekema
Nov 22, 2012·Expert Review of Clinical Immunology·Małgorzata MikulskaClaudio Viscoli
May 12, 2009·Expert Opinion on Investigational Drugs·Maria J G T RuepingOliver A Cornely
Dec 17, 2009·Expert Opinion on Pharmacotherapy·Jörg J VehreschildOliver A Cornely
Sep 9, 2010·The American Journal of the Medical Sciences·Peter G Pappas
Dec 15, 2010·Critical Care Clinics·Alexander Lepak, David Andes
Sep 21, 2006·Infectious Disease Clinics of North America·Peter G Pappas
Aug 21, 2009·Journal of Veterinary Emergency and Critical Care·Catherine L RogersElizabeth A Rozanski
Sep 9, 2008·Mycoses·Maria J G T RüpingOliver A Cornely
May 2, 2008·Pharmacotherapy·John MohrLuis Ostrosky-Zeichner
May 18, 2010·Hospital Practice·Sujatha Krishnan, Luis Ostrosky-Zeichner
Jun 25, 2016·Annals of Hematology·Andrew J UllmannUNKNOWN Infectious Diseases Working Party of the German Society for Hematology and Medical Oncology (AGIHO/DGHO) and the DAG-KBT (Ge
May 31, 2007·The Annals of Pharmacotherapy·Ryosuke TsurutaTsuyoshi Maekawa
Sep 23, 2006·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Michele I Morris, Mark Villmann
Apr 21, 2017·Turkish Journal of Medical Sciences·Aynur AtillaSırrı S Kiliç
Feb 5, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasUNKNOWN Infectious Diseases Society of America

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.